RVPH — REVIVA PHARMACEUTCLS HLDGS I

Ownership history in Persistent Asset Partners Ltd  ·  4 quarters on record

This page tracks every 13F SEC filing in which Persistent Asset Partners Ltd reported a position in REVIVA PHARMACEUTCLS HLDGS I (RVPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.25% (2024 Q4)
Avg. % of fund
0.18%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 593,902 -47,272 -7.4% 0.15% $219K $7.40
2025 Q2 ADDED 641,174 +480,864 +300.0% 0.18% $244K $7.60
2025 Q1 REDUCED 160,310 -860 -0.5% 0.13% $153K $19.00
2024 Q4 INITIATED 161,170 — — 0.25% $305K $36.20
% of Fund (quarterly)    RVPH price (monthly, adj. close)

Other funds also holding RVPH

As of 2025 Q4 — sorted by position size

Murchinson Ltd. 3Y 0.01% XTX Topco Ltd 3Y 0.0% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.0% CUTLER INVESTMENT COUNSEL LLC 3Y 7Y 0.0% BOOTHBAY FUND MANAGEMENT, LLC 3Y 7Y 0.0% MILLENNIUM MANAGEMENT LLC 3Y 7Y 0.0% BECKER CAPITAL MANAGEMENT INC 3Y 7Y 0.0% FLAGSHIP HARBOR ADVISORS, LLC 3Y 7Y 0.0% Larson Financial Group LLC 3Y 7Y 0.0% MILLENNIUM MANAGEMENT LLC 3Y 7Y 0.0%
← Back to Persistent Asset Partners Ltd Holdings